Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law & Ethics DPEE Test Noteskarts

Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law & Ethics DPEE Test

This test is Improve for Pharmacy exam like Diploma in Pharmacy exit exam MCQs (DPEE), GPAT, & other competitive exam. Pharmacy Law & Ethics Class Test | Pharmacy Law & Ethics DPEE Test

242

1 / 50

1. Grant of licence to manufacture a drug requires.

a. Form 25

b. Form 24

c. Form 27

d. Form 26

2 / 50

2. In 1954 one of the following act is passed

a. Poisonous Act.

b. Drug and magic Remedies Act

c. Narcotic and psychotropic substance Act

d. The Medical Termination of pregnancy Act

3 / 50

3. Schedule N states

a. List of minimum equipment for efficient running of pharmacy

b. Requirement of factory premises and hygienic condition to complied

c. Standard for cosmetics

d. List of minimum equipment required for manufacturing of drug.

4 / 50

4. Schedule C is related to

a. List of Biological and Immunological product

b. List of Ayurvedic product

c. List of Allopathic product

d. List of Homeopathy product

5 / 50

5. In Phase-2 trial following number of patient should be studied

a. 100 patients

b. 500 patients

c. 10-12 patients

d. 1-10 patients

6 / 50

6. Patent Act is established in

a. 1940

b. 1919

c. 1970

d. 1948

7 / 50

7. The schedule in Drug and Cosmetics Act that deals with requirement and guidelines of clinical trial, import and manufacture of new drug is

a. Schedule Y

b. Schedule F

c. Schedule O

d. Schedule M

8 / 50

8. Pro-forma for sending memorandum is included in which schedule?

a. D

b. Q

c. FF

d. A

9 / 50

9. Schedule…………… of Drugs and Cosmetics Act in Cludes requirements and guidelines on clinical trials for import and manufacturing of new drugs.

a. V

b. W

c. Y

d. X

10 / 50

10. Biological and Biotechnological products are included in schedule.

a. A

b. X

c. B

d. C and C1

11 / 50

11. Purpose of Phase-3 trial is

a. Efficacy and Safety of drug in longer number of patients (500 patients)

b. Long time adverse effects aster marketing drug

c. To determine maximum tolerated dose in humans, Pharmacodynamics effects, Adverse effect.

d. Determine Possible therapeutic uses, Effective doses range

12 / 50

12. The first edition of India Pharmacopoeia was published in the year :

a. 1940

b. 1985

c. 1950

d. 1955

13 / 50

13. The Education Regulation (ER) is published in official gazette by

a. Drug Controller

b. President, Pharmacy Council of India

c. Ministry of Education

d. Central Government

14 / 50

14. One of the following is/all ex officio member(s) of State Pharmacy Council

a. Assistant drug controller

b. All

c. Chief administrative medical officer of the state

d. Chief pharmacist of government hospital

15 / 50

15. List of coal tar colours permitted to be used in cosmetics is covered under.

a. Schedule Q

b. Schedule P

c. Schedule O

d. Schedule R

16 / 50

16. Which of the following is prohibited to be imported?

a. Ayurvedic drugs

b. Toilet preparations

c. Misbranded drugs

d. Schedule ‘C’ ‘G’ drugs

17 / 50

17. List of drugs which should be used by patient under medical supervision is covered under………..as per D & C Act.

a. Schedule G

b. Schedule J

c. Schedule H

d. Schedule I

18 / 50

18. Coca, opium and hemp come under:

a. Poisons Act

b. Spurious Drug Act

c. Dangerous Drug Act

d. Insecticide Act

19 / 50

19. Schedule X of Drugs and Cosmetics Act comprises

a. List of generic drugs

b. Guidelines for clinical Trials

c. None of the above

d. List of incurable diseases

20 / 50

20. Standard for mechanical contraceptive comes under Schedule ………………as per D & C Act

a. O

b. R

c. R1

d. S

21 / 50

21. MCC is regulatory agency of ……………

a. UK

b. Denmark

c. South Africa

d. Brazil

22 / 50

22. Post marketing surveillance comes under clinical trial

a. Phase II

b. Phase V

c. Phase III

d. Phase I

23 / 50

23. As per schedule P Carbenicillin Sodium Powder Should be Stored in/at

a. A Cold place

b. A cool place

c. Temperature not exceeding 5°C

d. Well closed container, protect from light, in cool place, protect from light

24 / 50

24. For licence granted to sell by retail drugs, specified in schedule C and C(1) drugs from no. require is

a. 20

b. 21

c. 20B

d. 21B

25 / 50

25. For parenteral preparation in glass containers minimum area required is

a. 150 square meters

b. 500 square meters

c. 400 square meters

d. 250 square meters

26 / 50

26. Example of Schedule G drug is

a. Cefuroxime

b. Barbital

c. Enalapril

d. Metformin

27 / 50

27. DTAB has ———————– ex officio members

a. Six

b. Eight

c. Four

d. Five

28 / 50

28. Kala jadu or Kavach comes under

a. Schedule J

b. Schedule L

c. Schedule K

d. Schedule P

29 / 50

29. If blood group is “AB” then colour label used is

a. Yellow

b. Blue

c. Red

d. White

30 / 50

30. For schedule X drug use of Human beings special labeling requirement require is

a. Symbol N is red displayed on left top corner of the label

b. Symbol X given in red

c. Symbol N displayed on left top corner of the label.

d. Symbol H displayed on right top corner of the label.

31 / 50

31. Injection syringe and needles are covered under

a. Schedule Q

b. Schedule A

c. Schedule P

d. Schedule B

32 / 50

32. Pharmacy Council of India (PCI) is reconstituted:

a. Every 2 year

b. Every 5 year

c. Every 3 year

d. Every 6 year

33 / 50

33. In State Pharmacy Council all following are ex officio members except.

a. The officer in charge of drugs control organization

b. Chief Administrator medical officer of state

c. President of India

d. Government Analyst

34 / 50

34. Dettol comes under

a. Schedule N

b. Schedule Q

c. Schedule P

d. Schedule O

35 / 50

35. As per D and C act schedule T stated about

a. Requirements of factory premises for the manufacture of Medical device

b. Requirements of factory premises for the manufacturer of Allopathy drugs

c. Requirements of factory premises for the manufacturer of Ayurveda, Sidhha and Unani drugs

d. Requirements of factory premises for the manufacturer of Homeopathy drugs

36 / 50

36. As per D & C Act “Schedule FF” is related with

a. Ophthalmic preparation

b. Skin cosmetic preparation

c. Ointment formulation

d. Parenteral preparation

37 / 50

37. Drug and Magic Remedies Act is enacted in

a. 1954

b. 1985

c. 1948

d. 1919

38 / 50

38. Schedule J is related to

a. List of disease and ailments which drug cannot claim.

b. GMP

c. Pack sizes of drugs.

d. Curable disease

39 / 50

39. MHRA is regulatory agency of ……….....

a. UK

b. South Africa

c. Denmark

d. Brazil

40 / 50

40. State Pharmacy Council should have the following number of elected members.

a. Six

b. Five

c. Seven

d. Nine

41 / 50

41. List of drugs whole import, manufacture and sale, labeling and packaging are governed by special provisions are included in schedule.

a. X

b. K

c. G

d. H

42 / 50

42. As per D and C Act “Schedule N” is related with

a. List of minimum equipments for efficiently running pharmacy

b. Area required to open wholesale drug store

c. List of maximum equipments for efficiently running pharmacy

d. Area for opening retail pharmacy

43 / 50

43. Aspirin sodium comes under

a. Schedule G

b. Schedule J

c. Schedule H

d. Schedule Y

44 / 50

44. Pharmacy Council of India contain comprises…….. Members (s) from AICTE and UGC.

a. 2

b. 1

c. 4

d. 3

45 / 50

45. Hatch Waxman Act is related to

a. Spurious drugs Act

b. Over the counter drugs

c. Banned drugs

d. Dangerous drugs Act

46 / 50

46. Schedule D as per D & C Act is concerned with

a. Requirements of factory premises

b. List of drug exempted from the provision of import of drugs

c. List of prescription drugs

d. Disease or ailments which a drug may not purport to prevent or cure

47 / 50

47. If drug is so colored, coated or polished that damage its therapeutic value or it is made to appear of better or greater therapeutic value than it really is known as

a. Misbranded Drug

b. True Drug

c. Adulterated Drug

d. Spurious Drug

48 / 50

48. Insulin injection according to schedule P is should be stored

a. At temperature which not exceed 5°C

b. In cold place

c. At the Temperature 2°C to 8°C and it must not allow to freeze

d. At temperature which not exceed 20°C

49 / 50

49. Pack size of drug is covered under

a. Schedule O

b. Schedule P

c. Schedule P1

d. Schedule R

50 / 50

50. TGA is regulatory agency of………….

a. Zimbabwe

b. Australia

c. Denmark

d. India

Your score is

The average score is 35%